Le Fonds européen de développement régional et la Wallonie investissent dans votre avenir.
RADAR - RApid Detection of Antibiotic Resistance
Le projet RADAR a pour objectif de développer de nouveaux tests d'identification de résistances aux antibiotiques.
Ce projet réalisé en partenariat par les sociétés Coris BioConcept et Synabs passe par la création de réactifs nécessaires au développement de nouveaux tests ainsi qu'à l'amélioration de tests existants afin d'étendre leur champ d'utilisation et permettre à Coris BioConcept d'étendre la gamme R.E.S.I.S.T. dédiée à ces identifications.
Subvention de 425.000€
dont FEDER : 170.000€ et Wallonie : 255.000€
HemoPOC - Diagnostic rapide des hémoglobinopathies
L’objectif poursuivi est le développement d’anticorps spécifiques de l’hémoglobine en vue de la détection par diagnostic rapide des hémoglobinopathies tels que la drépanocytose, l’alpha et béta-thalassémie, mais aussi le dosage de l’hémoglobine totale et d’autres variants.
Ce projet est réalisé en partenariat par les sociétés Zentech et Synabs.
Subvention de 486.000€
dont FEDER : 194.400€ et Wallonie : 291.600 €
Delivering unique monoclonal antibodies against difficult antigens and small molecules
SYnAbs' mission is to generate innovative antibodies against
poor immunogenic compounds and complex antigens.
Either as a custom service,
or as a catalog product,
you can benefit
from SYnAbs technologies
to get access to
singular monoclonal antibodies.
In SYnAbs they trust
Time to enjoy your free ebook :
"Proven strategies for successful antibodies generation against difficult antigens"
The benefits of SYnAbs unique technologies?
- Extreme specificity monoclonal antibodies
- Higher affinity binder monoclonal antibodies
- >90% success rate for small, difficult and poor immunogenic antigens
- Additional epitope recognition
- High and stable producer clones
- Access to multiple immune repertoires
- Raising antibodies against difficult to express antigens
- Generating antibodies against conformation sensitive targets thanks to DNA immunization
Innovative antibodies against small molecules
guinea pig anti-dihydrotestosterone
Uniqueness features:
- Higher affinity compared to other species
- Only mAb of guinea pig species on the market
Description: guinea pig anti-dihydrotestosterone
Class: monoclonal
Type: primary
Host/Isotype : guinea pig
IgG2a kappa rat anti-VHH
Uniqueness features:
- Only reference that can detect the 7 families of VHH
Description: IgG2a kappa rat anti-VHH
Class: monoclonal
Type: secondary
Host/Isotype : rat
IgG2b kappa rat anti-His tag (N-ter & C-ter)
Uniqueness features:
- Reference validated on 17 different recombinant proteins
- Detect both N-terminal & C-terminal sequences
Description: IgG2b kappa rat anti-His Tag
Class: monoclonal
Type: primary
IgG1 rat anti-human IgG4
Uniqueness features:
- No-cross reactivity with other human isotypes
- No paratope hiding when labelled with HRP
Description: rat anti-human IgG4
Class: monoclonal
Type: secondary
IgG1 kappa rat anti-dinitrophenyl hapten
Uniqueness features:
- Best reference to detect DNP on DNA, RNA...
- Advantageously replaces biotin-streptavidin
- Best sales in USA
Description: IgG1 kappa rat anti-dinitrophenyl hapten
Class: monoclonal
Type: primary, irrelevant
Where to meet SYnAbs in 2020?
Feb 3rd- Feb 6th
Feb 4th - Feb 5th
Feb 5th - Feb 6th
Sept 9th - Sept 10th
Oct 7th - Oct 8th
Nov 11th - Nov 13th
Nov 16th - Nov 19th
Dec 7th
Dec 8th - Dec 9th
Dec 10th
Dec 10th - Dec 13th
Dubai, Emirates, Medlab
Evreux, France, Polepharma Biotesting Day
Strasbourg, France, Bioproduction Buzz4Bio
Ghent, Belgium, Knowledge for Growth
Gosselies, Belgium, Cell&Gene Buzz4Bio
Oxford, United Kingdom, HAH
Dusseldorf, Germany, MEDICA
Ghent, Belgium, BIS Satellite meeting
Ghent, Belgium, Translational Immunology
Louvain-la-Neuve, Belgium, BioWin Day
Chicago, USA, AACC
